AI is transforming care. Hospitals are adopting high-tech systems to improve diagnoses and recommend treatments, but there’s little formal regulation. The Food and Drug Administration, which oversees some of the tools, may not have all of the authority it needs to monitor products that can evolve over time, as they take in more information, and would need a much larger staff to do so, former FDA Commissioner Robert Califf has said.
That’s one reason the Biden administration was enthused about CHAI, which promised to establish private-sector-led labs to test AI tools and advise doctors and hospitals on how they work. Two Biden administration officials served on CHAI’s board, lending it credibility with prospective private sector members.
Continue Reading on Politico
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.